Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2A | P28223 | 1/20 | 0.67 |
| ▸ | BCL9 | O00512 | 1/20 | 0.47 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10490876 | 0.94 | HTR2A (0.67) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL5827968 | 0.90 | HTR2A (0.80) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL1714950 | 0.86 | HTR2A (0.70) | HTR2ABCL9CTNNB1RAB9AALDH1A1 | |
| SCHEMBL14621621 | 0.86 | HTR2A (0.74) | HTR2ABCL9CTNNB1MAOBGAA | |
| Water SCHEMBL10938437 | 0.85 | HTR2A (0.73) | HTR2ABCL9CTNNB1MAOBGAA | |
| Water SCHEMBL10938430 | 0.85 | HTR2A (0.73) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL6594172 | 0.83 | HTR2A (0.74) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL20480867 | 0.83 | HTR2A (0.70) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL4112112 | 0.83 | HTR2A (0.74) | HTR2ABCL9CTNNB1MAOBGAA | |
| SCHEMBL25187205 | 0.83 | HTR2A (0.70) | HTR2ABCL9CTNNB1MAOBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4021916-A1 | 4'-ETHYNYL-2'-DEOXYADENOSINE DERIVATIVES AND THEIR USE IN HIV THERAPY | GlaxoSmithKline Intellectual Property (No. 2) Limited (GB) | 2022-07-06 | — | — | EP | disclosed |
| WO-2021038509-A1 | 4'-ETHYNYL-2'-DEOXYADENOSINE DERIVATIVES AND THEIR USE IN HIV THERAPY | GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.2) LIMITED (GB) | 2021-03-04 | — | — | WO | disclosed |